Reuters Health

India's Torrent Pharma reported a 20% jump in its first-quarter profit on Monday, driven by demand for drugs used to treat long-term conditions. reut.rs/4oaJJHG

From Breakingviews - Berlusconis test investor faith in pan-European TV reut.rs/3H5vu6q

British cell and gene therapy manufacturer Oxford Biomedica said on Monday it expects first-half sales to jump around 40% as orders remain strong, and maintained its annual forecasts for revenue and profit. reut.rs/4lQnUfe

India's Torrent Pharma reported a 20% jump in its first-quarter profit on Monday, driven by demand for drugs used to treat long-term conditions. reut.rs/4o7fCAW

From Breakingviews - Berlusconis test investor faith in pan-European TV reut.rs/4lRDFm5

British cell and gene therapy manufacturer Oxford Biomedica said on Monday it expects first-half sales to jump around 40% as orders remain strong, and maintained its annual forecasts for revenue and profit. reut.rs/45ow3By

A consortium led by Nordic Capital and Permira has made an around $3 billion offer to buy all shares in Bavarian Nordic , the vaccine maker said on Monday. reut.rs/4mfCPzg

India's Torrent Pharma reported a 20% jump in its first-quarter profit on Monday, driven by demand for drugs used to treat long-term conditions. reut.rs/46uIjBJ

Britain's GSK and China's Jiangsu Hengrui Pharmaceuticals have agreed on a $500 million deal to develop up to a dozen new medicines, including a promising candidate for a chronic lung condition, the drugmakers said on Monday. reut.rs/453tjs0

British cell and gene therapy manufacturer Oxford Biomedica said on Monday it expects first-half sales to jump around 40% as orders remain strong, and maintained its annual forecasts for revenue and profit. reut.rs/3TZT2wo

A consortium led by Nordic Capital and Permira has made an around $3 billion offer to buy all shares in Bavarian Nordic , the vaccine maker said on Monday. reut.rs/419L2wI

China's Jiangsu Hengrui Pharmaceuticals said on Monday it has agreed to license the global rights of its HRS-9821 drug and 11 other programmes to GlaxoSmithKline Intellectual Property (GSK) for $500 million upfront. reut.rs/458Y0fB

Consortium led by Nordic Capital, Permira to acquire Bavarian Nordic reut.rs/4lUf00i

China's Jiangsu Hengrui Pharmaceuticals said on Monday it has agreed to license the global rights of its HRS-9821 drug and 11 other programmes to GlaxoSmithKline Intellectual Property (GSK) for $500 million upfront. reut.rs/4fdF7ww

David Nabarro, the World Health Organization's special envoy for COVID-19 since the early stages of the outbreak in 2020, has died at the age of 75, the WHO said on Saturday. reut.rs/4f6oNxs

Atai Life Sciences and its partner Recognify Life Sciences said on Friday their experimental drug did not meet the main goal in a mid-stage trial for patients with schizophrenia-linked cognitive impairment. reut.rs/4l3Yeuh

Over five years after the COVID-19 outbreak, Honduras has reinstated mandatory mask wearing in public spaces amid a spike in respiratory illnesses and as a variant of the virus spreads through the Central American country. reut.rs/3IMSK9N

At least 652 children died from malnutrition in the Nigerian state of Katsina in the first six months of 2025, Mèdecìns Sans Frontières said on Friday, an outcome it said it was due to funding cuts by international donors. reut.rs/4f7JGZf

Atai Life Sciences and its partner Recognify Life Sciences said on Friday their experimental drug did not meet the main goal in a mid-stage trial for patients with schizophrenia-linked cognitive impairment. reut.rs/44NRN9T

Over five years after the COVID-19 outbreak, Honduras has reinstated mandatory mask wearing in public spaces amid a spike in respiratory illnesses and as a variant of the virus spreads through the Central American country. reut.rs/4kSVtfb